Formulation and development of taste masked fast-disintegrating tablets (FDTs) of Chlorpheniramine maleate using ion-exchange resins

References

• Sugao H, Yamazaki S, Shiozawa H, Yano K. Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles. J Pharm Sci 1998;87:96–100.
   PubMed Web of Science ®Google Scholar
• Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm 2004;30:429–448.
   PubMed Web of Science ®Google Scholar
• Bakan JA, Microencapsulation. In: Lachman L, Liberman HA, Kanig JL (eds). The theory and practice of Industrial Pharmacy. Marcel Dekker, Bombay; 1991: p. 413.
   Google Scholar
• Goldburg AH, Skar AA. Anionic exchanger polymeric complexes of Buspirone. 2000. U.S. Patent, 6268368.
   Google Scholar
• Metcalf, et al. Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin. 2001. U.S. Patent, 6193962.
   Google Scholar
• Borodkin S, Sundberg DP. Polycarboxylic acid ion-exchange resin adsorbates for taste coverage in chewable tablets. J Pharm Sci 1971;60:1523–1527.
   PubMed Web of Science ®Google Scholar
• Friend D, Ng S, Sabaria R, Weber T, Geoffroy J. Taste masked microcapsule composition and method of manufacture. 2000. U.S. Patent, 6139865.
   Google Scholar
• Eby GA. Flavour stable zinc acetate composition for oral absorption. 1992. U.S. Patent, 5095035.
   Google Scholar
• Sinkula AA, Lewis C. Chemical modification of lincomycin: synthesis and bioactivity of selected 2,7-dialkylcarbonate esters. J Pharm Sci 1973;62:1757–1760.
   PubMedGoogle Scholar
• Maurin MB, Hussain AA. Dosage Form Design: A Physicochemical Approach. In: Swarbrick J, Boylan CJ. (eds). Encyclopaedia of Pharamaceutical Technology. Informa Healthcare., New York, 2007: p. 942.
   Google Scholar
• Jones PH, Rowley E, Weiss AL, Bishop DL, Chun AH. Insoluble erythromycin salts. J Pharm Sci 1969;58:337–339.
   PubMed Web of Science ®Google Scholar
• Xu J, Bovet LL, Zhao K. Taste masking microspheres for orally disintegrating tablets. Int J Pharm 2008;359:63–69.
   PubMed Web of Science ®Google Scholar
• Ansel HC, Popovich NG, Allen LV. Pharmaceutical dosage forms and drug delivery system. New Delhi. B.I. Waverly Pvt. Ltd., 1995:189–236.
   Google Scholar
• Cuña M, Vila Jato JL, Torres D. Controlled-release liquid suspensions based on ion-exchange particles entrapped within acrylic microcapsules. Int J Pharm 2000;199:151–158.
   PubMed Web of Science ®Google Scholar
• Ichikawa H, Fujioka K, Adeyeye MC, Fukumori Y. Use of ion-exchange resins to prepare 100 microm-sized microcapsules with prolonged drug-release by the Wurster process. Int J Pharm 2001;216:67–76.
   PubMed Web of Science ®Google Scholar
• Sriwongjanya M, Bodmeier R, Entrapment of drug loaded ion-exchange particles within polymer microparticles. Int J Pharm 1997;158:29–38.
   Web of Science ®Google Scholar
• Douroumis D. Practical approaches of taste masking technologies in oral solid forms. Expert Opin Drug Deliv 2007;4:417–426.
   PubMed Web of Science ®Google Scholar
• Singh I, Kaur B, Kumar P, Arora S. Masking the unpleasant taste of etoricoxib by crosslinked acrylic polymer based ion-exchange resin complexation. Polim Med 2010;40:19–26.
   PubMedGoogle Scholar
• Shah S, Pandya S, Bhalekar M. Molecular properties and evaluation of indion 234-ondansetron resinates. J Young Pharm 2010;2:247–251.
   PubMedGoogle Scholar
• Bhoyar PK, Biyani DM. Formulation and In vitro Evaluation of Sustained Release Dosage Form with Taste Masking of Metformin Hydrochloride. Indian J Pharm Sci 2010;72:184–190.
   PubMedGoogle Scholar
• Pharmacopoeia of India, Ministry of Health and Family Welfare, Govt. of India, the Indian Pharmacopoeia Commission, Ghaziabad, Vol II, 2007: p. 301.
   Google Scholar
• United State Pharmacopoeia 30/ NF 25. The Official Compendia of Standards, United State Pharmacopoeial Convention Inc., Rockville, 2007: 277, 1177, 1743, 3203.
   Google Scholar
• Douroumis DD, Gryczke A, Schminke S. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets. AAPS PharmSciTech 2011;12:141–151.
   PubMed Web of Science ®Google Scholar
• Shishu, Kamalpreet, Kapoor VR. Development of taste masked oral formulation of ornidazole. Indian J Pharm Sci 2010;7:211–215.
   Google Scholar
• Mizumoto T, Tamura T, Kawai H, Kajiyama A, Itai S. Formulation design of taste-masked particles, including famotidine, for an oral fast-disintegrating dosage form. Chem Pharm Bull 2008;56:530–535.
   PubMed Web of Science ®Google Scholar
• Akkaramongkolporn P, Terada K, Yonemochi E. Molecular properties of propranolol hydrochloride prepared as drug-resin complexes. Drug Dev Ind Pharm 2001;27:359–364.
   PubMed Web of Science ®Google Scholar
• Padalkar AN, Shahi SR, Udavant YK, Salunke RJ, Kuchekar BS. An approach towards taste abatement of Roxithromycin. IJPRD 2009;1:1–13.
   Google Scholar
• Bhoyar P, Biyani D, Umekar M. Formulation and characterization of patient-friendly dosage form of ondansetron hydrochloride. J Young Pharm 2010;2:240–246.
   PubMedGoogle Scholar
• Ansel HC, Popovich NG, Allen LV. Pharmaceutical dosage forms and drug delivery system. New Delhi. B.I. Waverly Pvt. Ltd., 1995:189–194, 235–236.
   Google Scholar
• Sunada H, Bi YX, Yonezawa Y, Danjo K. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 2002;122:188–198.
   Web of Science ®Google Scholar
• United State Pharmacopoeia 30/ NF 25. The Official Compendia of Standards, United State Pharmacopoeial Convention Inc., Rockville, 2007: 277, 1177, 1743, 3203.
   Google Scholar
• Rangole US, Kawtikwar PS, Sakarkar DM. Formulation and in vitro Evaluation of Rapidly. Disintegrating Tablets Using Hydrochlorothiazide as a Model Drug. RJPT 2008;1:349–352.
   Google Scholar
• Mundada AS, Meshram DR, Banbale HB, Bhalekar MR, Avari JG. Formulation and evaluation of dispersible taste masked tablet of roxithromycin. Asian J Pharm 2008;2:116–119.
   Google Scholar